Duramune Cv-K (Canada)

Manufacturer: Boehringer

Canine Coronavirus Vaccine

Killed Virus

Veterinary Use Only

Duramune Cv-K Indications

For vaccination of healthy dogs 6 weeks of age or older as an aid in the prevention of disease caused by canine coronavirus.

Directions For Use

Dogs, inject one 1 mL dose subcutaneously or intramuscularly using aseptic technique. All dogs over 12 weeks of age should initially receive one dose of Duramune Cv-K and a second dose 2 to 3 weeks later. Annual revaccination with one dose is recommended.

A recommended vaccination should start at or about 6 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity. Puppies should be revaccinated every 2 to 3 weeks until they are at least 12 weeks of age.

Precautions

Store in dark at 2-7°C. Do not freeze. Shake well. Use entire contents when first opened. In case of anaphylactoid reaction, administer epinephrine.

Preservatives

Gentamicin, thimerosal and amphotericin B.

Duramune^® is a registered trademark of Boehringer Ingelheim Vetmedica, Inc. Used under license.

Manufactured By: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.s.a.

U.s. Veterinary License No. 124

Manufactured For: Boehringer Ingelheim (canada) Ltd., Burlington, Ontario L7l 5h4

10 mL/10 Doses

150601-00

Nac No.

12300781